{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:46:09Z","timestamp":1762868769712,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Waldenstrom macroglobulinemia (WM) is a rare lymphoma with an incidence rate of 3 per million people per year, with approximately 1000 to 1500 new cases diagnosed each year in the USA. It is primarily seen in Caucasian males with a median age of 70 years old. Patients are most often asymptomatic, but WM can manifest itself with constitutional symptoms such as lethargy, bleeding, organomegaly, and neurological or fundoscopic abnormalities. WM is characterized by immunoglobulin M (IgM) monoclonal gammopathy, lymphocytic infiltration of bone marrow, and normocytic anemia due to bone marrow replacement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Our patient is a Hispanic 67-year-old female that presents with one month of intermittent band-like bilateral headache accompanied by dizziness, light-headedness, nausea, and blurred vision. A thorough diagnostic workup was performed, including serum protein electrophoresis (SPEP) with serum immunofixation (SIFE) showing an M spike and IgM kappa. Bone marrow biopsy was significant for lymphoplasmacytic infiltration with nodular B cells (CD19+, CD20+, CD22+). Computerized Tomography (CT) imaging showed splenomegaly in the patient. Treatment was provided for hyperviscosity syndrome with plasmapheresis twice. The patient reported improvement of her symptoms and was then scheduled for chemotherapy. Throughout 7 months, our patient received multiple cycles of bortezomib, dexamethasone, and rituximab. While her symptoms improved her psychiatric status got progressively worse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>It is important not to neglect symptoms such as a headache, which may seem small, but could serve as a clue in the diagnosis of Waldenstrom's macroglobulinemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-022-00107-6","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:02:29Z","timestamp":1646611349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Simple headache revealed a rare lymphoma: Waldenstrom macroglobulinemia with unique markers: a case report and review of the literature"],"prefix":"10.1186","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-1866","authenticated-orcid":false,"given":"Ahmed K.","family":"Awad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7923-9131","authenticated-orcid":false,"given":"Merihan A.","family":"Elbadawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maty","family":"Boury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Motawea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffer","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanli","family":"Parnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Varney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"107_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the second international workshop on Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30:110\u20135.","journal-title":"Semin Oncol"},{"key":"107_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000205464","volume":"20","author":"J Waldenstrom","year":"1958","unstructured":"Waldenstrom J. Macroglobulinaemia. Acta Haematol. 1958;20:33\u20139.","journal-title":"Acta Haematol"},{"key":"107_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/modpathol.2009.34","volume":"22","author":"WG Morice","year":"2009","unstructured":"Morice WG, Chen D, Kurtin PJ, et al. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom\u2019s macroglobulinemia. Mod Pathol. 2009;22:807\u201316.","journal-title":"Mod Pathol"},{"key":"107_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/sonc.2003.50054","volume":"30","author":"M Bjorkholm","year":"2003","unstructured":"Bjorkholm M, Johansson E, Papamichael D, et al. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom\u2019s macroglobulinemia: a two-institution study. Semin Oncol. 2003;30:226\u201330.","journal-title":"Semin Oncol"},{"key":"107_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-2007-994921","volume":"25","author":"HC Kwaan","year":"1999","unstructured":"Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost. 1999;25:199\u2013208.","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"107_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","volume":"27","author":"P Lin","year":"2003","unstructured":"Lin P, Bueso-Ramos C, Wilson CS, Mansoor A, Medeiros LJ. Am J Surg Pathol. 2003;27(8):1104\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"107_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clinimag.2008.12.006","volume":"33","author":"P Gupta","year":"2009","unstructured":"Gupta P, Rice GD, Abraham K, Ghole V, Ketkar M. Extramedullary plasmacytoma of the pancreas and jejunum. Clin Imaging. 2009;33(3):240\u20133.","journal-title":"Clin Imaging"},{"issue":"1","key":"107_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3324\/haematol.2016.147728","volume":"102","author":"MC Minnema","year":"2017","unstructured":"Minnema MC, Kimby E, D'Sa S, et al. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017;102(1):43\u201351. https:\/\/doi.org\/10.3324\/haematol.2016.147728.","journal-title":"Haematologica."},{"issue":"1","key":"107_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/bjh.13264","volume":"169","author":"JJ Castillo","year":"2015","unstructured":"Castillo JJ, Olszewski AJ, Kanan S, et al. Overall survival and competing risks of death in patients with Waldenstrom macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database. Br J Haematol. 2015;169(1):81\u20139.","journal-title":"Br J Haematol"},{"issue":"2","key":"107_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajh.25292","volume":"94","author":"MA Gertz","year":"2019","unstructured":"Gertz MA. Waldenstr\u00f6m macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019;94(2):266\u201376. https:\/\/doi.org\/10.1002\/ajh.25292 Epub 2018 Oct 17. PMID: 30328142.","journal-title":"Am J Hematol"},{"issue":"3","key":"107_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.mayocp.2019.01.021","volume":"94","author":"E Kastritis","year":"2019","unstructured":"Kastritis E, Dimopoulos MA. A 50-Year-Long Study of Waldenstr\u00f6m Macroglobulinemia. Mayo Clin Proc. 2019;94(3):394\u20136. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.021 PMID: 30832789.","journal-title":"Mayo Clin Proc"},{"key":"107_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/088506669501000304","volume":"10","author":"MA Gertz","year":"1995","unstructured":"Gertz MA, Kyle RA. Hyperviscosity syndrome. J Intensive Care Med. 1995;10:128\u201341 65. Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119:2205-2208.","journal-title":"J Intensive Care Med"},{"key":"107_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2009.25.3237","volume":"28","author":"IM Ghobrial","year":"2010","unstructured":"Ghobrial IM, Hong F, Padmanabhan S, et al. Phase II trial of weekly Bortezomib in combination with Rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia. J Clin Oncol. 2010;28:1422\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"107_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","volume":"124","author":"MA Dimopoulos","year":"2014","unstructured":"Dimopoulos MA, Kastritis E, Owen RG, et al. Treatment recommendations for patients with Waldenstr\u00f6m macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood. 2014;124(9):1404\u201311. https:\/\/doi.org\/10.1182\/blood-2014-03-565135.","journal-title":"Blood"},{"key":"107_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.critrevonc.2016.06.004","volume":"105","author":"A Santos-Lozano","year":"2016","unstructured":"Santos-Lozano A, Morales-Gonzalez A, Sanchis-Gomar F, et al. Response rate to the treatment of Waldenstrom macroglobulinemia: a meta-analysis of the results of clinical trials. Crit Rev Oncol Hematol. 2016;105:118\u201326.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-022-00107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-022-00107-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-022-00107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:04:27Z","timestamp":1646611467000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-022-00107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1186\/s43046-022-00107-6","relation":{},"ISSN":["2589-0409"],"issn-type":[{"type":"electronic","value":"2589-0409"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The case report was performed following the declaration of Helsinki and approved by the Drexel University College of Medicine Hospital ethics committee according to the international guidelines and ethics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was taken from the patient\u2019s parents and uploaded as a supplementary file for review by the editor-in-chief.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}